Published in Oncogene on March 30, 2006
Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet (2009) 1.43
Analysis of variants in DNA damage signalling genes in bladder cancer. BMC Med Genet (2008) 0.99
Analysis of microsatellite instability in medulloblastoma. Neuro Oncol (2009) 0.87
Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer. Virchows Arch (2006) 0.87
Implication of microsatellite instability in human gastric cancers. Indian J Med Res (2012) 0.80
MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea. Br J Cancer (2009) 0.80
Causal link between microsatellite instability and hMRE11 dysfunction in human cancers. Mol Cancer Res (2011) 0.79
Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours. Oncotarget (2014) 0.79
Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. Oncotarget (2015) 0.75
Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome. Mod Pathol (2016) 0.75
Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human Hepatocellular Carcinoma. Cancer Genomics Proteomics (2017) 0.75
Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet (1999) 2.79
BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res (1997) 2.77
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol (2001) 2.55
Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem (1993) 2.46
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer (1998) 2.09
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene (2006) 2.07
Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine (2001) 2.06
DNA from soil mirrors plant taxonomic and growth form diversity. Mol Ecol (2012) 2.03
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries. Int J Tuberc Lung Dis (2005) 2.01
Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med (1999) 1.91
Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90
Diagnosis and management of seminal vesicle cysts associated with ipsilateral renal agenesis: a pooled analysis of 52 cases. Eur Urol (1998) 1.90
Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate (1996) 1.85
The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res (2000) 1.77
Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum Mol Genet (2001) 1.74
Adverse events in phase-I studies: a report in 1015 healthy volunteers. Eur J Clin Pharmacol (1998) 1.73
Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology (1996) 1.73
The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int (1999) 1.71
Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.68
Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene (2001) 1.64
ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem (1996) 1.63
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability. Oncogene (2007) 1.50
Interactions between mycoplasmas and the immune system. Immunol Rev (1989) 1.50
Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. J Urol (1997) 1.50
Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol (1996) 1.48
Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene (1997) 1.47
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res (2001) 1.46
Hirsutism and acne in women: coordinated radioimmunoassays for eight relevant plasma steroids. Clin Chem (1994) 1.46
Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res (1999) 1.46
A novel gold nanoparticles-based assay for rapid detection of Melissococcus plutonius, the causative agent of European foulbrood. Vet Rec (2012) 1.44
Sandwich-type enzyme immunoassay for big endothelin-I in plasma: concentrations in healthy human subjects unaffected by sex or posture. Clin Chem (1997) 1.43
Subcutaneous urinary diversions for palliative treatment of pelvic malignancies. J Urol (1995) 1.42
DNA metabarcoding multiplexing and validation of data accuracy for diet assessment: application to omnivorous diet. Mol Ecol Resour (2013) 1.39
The clinical implications of the prostate cancer prevention trial. BJU Int (2003) 1.38
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Ann Oncol (2009) 1.29
Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem (2001) 1.28
TEL-JAK2 transgenic mice develop T-cell leukemia. Blood (2000) 1.26
Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy. Lancet (2002) 1.26
Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation (2001) 1.25
Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors. Cancer Res (2001) 1.23
Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med (1995) 1.22
Mucin gene expression in the human endocervix. Hum Reprod (1995) 1.22
Variability of immunohistochemical reactivity on stored paraffin slides. J Clin Pathol (1998) 1.22
Management of prostate-specific antigen relapse in prostate cancer: a European Consensus. Int J Clin Pract (2004) 1.20
Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect Immun (1994) 1.20
Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood (1998) 1.18
TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene (2006) 1.17
CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome. J Med Genet (2013) 1.16
Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol (1991) 1.16
Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene (1993) 1.15
The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis. Leukemia (2009) 1.15
Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology (1996) 1.14
Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation (1979) 1.14
Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res (2000) 1.13
Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene (1995) 1.12
Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum (1993) 1.11
Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Eur Urol (2004) 1.10
Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut (1995) 1.09
[Percutaneous renal surgery. Analysis of 100 cases of percutaneous nephrolithotomy]. Ann Urol (Paris) (1984) 1.09
Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer (1999) 1.09
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches. Br J Cancer (2011) 1.08
Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination. Urology (2001) 1.07
Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood (1993) 1.06
Cellular and molecular pathology of prostate cancer precursors. Scand J Urol Nephrol Suppl (2000) 1.06
Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines. Oncogene (1996) 1.06
Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells. J Virol (1985) 1.05
Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Immunol (1995) 1.05
Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis. Oncogene (2007) 1.04
Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet (2000) 1.04
Histochemical and ultrastructural study of diffuse melanoderma after bone marrow transplantation. Br J Dermatol (1996) 1.04
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.04
Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig Dis Sci (1989) 1.04
[Leiomyoma of the urinary excretory tract]. Ann Urol (Paris) (1989) 1.03
Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum (1993) 1.02
Confocal microscopy in cornea guttata and Fuchs' endothelial dystrophy. Br J Ophthalmol (1999) 1.02
A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum. J Immunol Methods (1982) 1.02
Variations in arterial blood supply and the risk of hemorrhage during percutaneous treatment of lesions of the pelviureteral junction obstruction: report of a case of testicular artery arising from an inferior polar renal artery. Surg Radiol Anat (1993) 1.01
Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol (1994) 1.01
Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues. Methods (2009) 1.00
Ureteral and bladder lesions after ballistic, ultrasonic, electrohydraulic, or laser lithotripsy. J Endourol (1994) 0.99
In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol (2006) 0.99
The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol (1996) 0.99
Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipients. Transplantation (2001) 0.98
Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia. Leukemia (2013) 0.98
Abnormal mucus in cap polyposis. Gut (1998) 0.98
Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer (2003) 0.97
Infrequent microsatellite instability in oesophageal cancers. Br J Cancer (1997) 0.97
Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability. Oncogene (1999) 0.97
Unresolved issues in laparoscopic splenectomy. Am J Surg (1996) 0.96
Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings. Transfus Med (2007) 0.95
Argon laser induced autofluorescence may distinguish between normal and tumor human urothelial cells: a microspectrofluorimetric study. J Urol (1996) 0.95
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer. Br J Cancer (2008) 0.95
Evidence for eosinophil activation in eosinophilic cystitis. Eur Urol (1994) 0.95